Proteinase 3 is an IL-32 binding protein.

IL-32, a recently discovered proinflammatory cytokine with four isoforms, induces IL-1beta, TNF-alpha, IL-6, and chemokines. Here, we used ligand (IL-32alpha) affinity chromatography in an attempt to isolate an IL-32alpha soluble receptor or binding protein. Recombinant IL-32alpha was covalently immobilized on agarose, and preparations of concentrated crude human urinary proteins were applied for chromatographic separation. A specific 30-kDa protein eluted from the column during acid washing and was identified by mass spectrometry as proteinase 3 (PR3) and confirmed by N-terminal microsequencing. PR3, a neutrophil granule serine protease, exists in a soluble or membrane form and is the major autoantigen for autoantibodies in the systemic vasculitic disease, Wegener's granulomatosis. The affinity of IL-32alpha to PR3 was determined by surface plasmon resonance. The dissociation constants were 2.65 +/- 0.4 nM for urinary PR3 and 1.2 +/- 0.05 nM for neutrophil-derived PR3. However, irreversible inactivation of PR3 enzymatic activity did not significantly change binding to the cytokine. Nevertheless, limited cleavage of IL-32 yielded products consistent with PR3 enzyme activity. Moreover, after limited cleavage by PR3, IL-32alpha was more active than intact IL-32alpha in inducing macrophage inflammatory protein-2 in mouse macrophages and IL-8 in human peripheral blood mononuclear cells. We suggest that PR3 is a specific IL-32alpha binding protein, independent of its enzymatic activity. However, limited cleavage of IL-32alpha by PR3 enhances activities of the cytokine. Therefore, specific inhibition of PR3 activity to process IL-32 or neutralization of IL-32 by inactive PR3 or its fragments may reduce the consequences of IL-32 in immune regulated diseases.

[1]  J. Wallace,et al.  A major role for proteolytic activity and proteinase-activated receptor-2 in the pathogenesis of infectious colitis. , 2005, Proceedings of the National Academy of Sciences of the United States of America.

[2]  B. Dewald,et al.  The polymorphonuclear leukocyte , 2005, Agents and Actions.

[3]  N. Ling,et al.  Expression and characterization of a putative high affinity human soluble leptin receptor. , 1997, Endocrinology.

[4]  E. Csernok,et al.  Transforming growth factor‐beta (TGF‐β) expression and interaction with proteinase 3 (PR3) in anti‐neutrophil cytoplasmic antibody (ANCA)‐associated vasculitis , 1996, Clinical and experimental immunology.

[5]  M. Netea,et al.  IL-32 synergizes with nucleotide oligomerization domain (NOD) 1 and NOD2 ligands for IL-1beta and IL-6 production through a caspase 1-dependent mechanism. , 2005, Proceedings of the National Academy of Sciences of the United States of America.

[6]  H. Kutsuna,et al.  Proteolytic Conversion of STAT3α to STAT3γ in Human Neutrophils , 2004, Journal of Biological Chemistry.

[7]  Huiling He,et al.  Identification of a novel gene expressed in activated natural killer cells and T cells. , 1992, Journal of immunology.

[8]  A. Tropsha,et al.  Autoimmunity is triggered by cPR-3(105–201), a protein complementary to human autoantigen proteinase-3 , 2004, Nature Medicine.

[9]  C. Kallenberg,et al.  Neutrophil membrane expression of proteinase 3 (PR3) is related to relapse in PR3-ANCA-associated vasculitis. , 2002, Journal of the American Society of Nephrology : JASN.

[10]  A. Malkinson,et al.  Decreased content of the IL1 alpha processing enzyme calpain in murine bone marrow-derived macrophages after treatment with the benzene metabolite hydroquinone. , 1994, Toxicology letters.

[11]  P. Heeringa,et al.  Internalization of proteinase 3 is concomitant with endothelial cell apoptosis and internalization of myeloperoxidase with generation of intracellular oxidants. , 2001, The American journal of pathology.

[12]  J. Wallace,et al.  Induction of intestinal inflammation in mouse by activation of proteinase-activated receptor-2. , 2002, The American journal of pathology.

[13]  C. Coeshott,et al.  Converting enzyme-independent release of tumor necrosis factor alpha and IL-1beta from a stimulated human monocytic cell line in the presence of activated neutrophils or purified proteinase 3. , 1999, Proceedings of the National Academy of Sciences of the United States of America.

[14]  S. Roman-Roman,et al.  In Vitro Processing of Human Tumor Necrosis Factor-α (*) , 1995, The Journal of Biological Chemistry.

[15]  S. Sugawara,et al.  Proinflammatory Cytokines Induce Proteinase 3 as Membrane-Bound and Secretory Forms in Human Oral Epithelial Cells and Antibodies to Proteinase 3 Activate the Cells through Protease-Activated Receptor-21 , 2004, The Journal of Immunology.

[16]  E. Unanue,et al.  Identification of a membrane-associated interleukin 1 in macrophages. , 1985, Proceedings of the National Academy of Sciences of the United States of America.

[17]  P. Hiemstra,et al.  Proteinase 3, the major autoantigen of Wegener's granulomatosis, enhances IL-8 production by endothelial cells in vitro. , 1996, Journal of the American Society of Nephrology : JASN.

[18]  W. Gross,et al.  Wegener’s Granulomatosis , 2004, Herz.

[19]  C. Kallenberg,et al.  Membrane proteinase 3 expression on resting neutrophils as a pathogenic factor in PR3-ANCA-associated vasculitis. , 2003, Clinical and experimental rheumatology.

[20]  D. Wallach,et al.  Two tumor necrosis factor-binding proteins purified from human urine. Evidence for immunological cross-reactivity with cell surface tumor necrosis factor receptors. , 1990, The Journal of biological chemistry.

[21]  R. Falk,et al.  Small-vessel vasculitis. , 1997, The New England journal of medicine.

[22]  M. Griese,et al.  Proteolysis of Surfactant Protein D by Cystic Fibrosis Relevant Proteases , 2003, Lung.

[23]  D. Bernstein,et al.  Delayed Onset of Inflammation in Protease-Activated Receptor-2-Deficient Mice1 , 2000, The Journal of Immunology.

[24]  D. Yoon,et al.  Interleukin-32: a cytokine and inducer of TNFalpha. , 2005, Immunity.

[25]  C. Perez,et al.  A novel form of TNF/cachectin is a cell surface cytotoxic transmembrane protein: Ramifications for the complex physiology of TNF , 1988, Cell.

[26]  R. Schreiber,et al.  Control of ion transport in mammalian airways by protease activated receptors type 2 (PAR‐2) , 2005, FASEB journal : official publication of the Federation of American Societies for Experimental Biology.

[27]  H. Okamura,et al.  Neutrophil Proteinase 3-Mediated Induction of Bioactive IL-18 Secretion by Human Oral Epithelial Cells1 , 2001, The Journal of Immunology.

[28]  D. Foell,et al.  Wegener granulomatosis in childhood and adolescence , 2004, European Journal of Pediatrics.

[29]  G. Fantuzzi,et al.  IL-1β-converting enzyme (caspase-1) in intestinal inflammation , 2001, Proceedings of the National Academy of Sciences of the United States of America.

[30]  V. Witko-Sarsat,et al.  Proteinase 3 mRNA expression is induced in monocytes but not in neutrophils of patients with cystic fibrosis , 1999, FEBS letters.

[31]  M. Baggiolini,et al.  Interleukin‐8 processing by neutrophil elastase, cathepsin G and proteinase‐3 , 1994, FEBS letters.

[32]  L. Hengst,et al.  Proteinase 3 sidesteps caspases and cleaves p21(Waf1/Cip1/Sdi1) to induce endothelial cell apoptosis. , 2004, Kidney international.

[33]  A. M. Muller Kobold,et al.  Leucocyte membrane expression of proteinase 3 correlates with disease activity in patients with Wegener's granulomatosis. , 1998, British journal of rheumatology.

[34]  D. Wallach,et al.  Soluble cytokine receptors are present in normal human urine , 1989, The Journal of experimental medicine.

[35]  U. Gullberg,et al.  A secreted proform of neutrophil proteinase 3 regulates the proliferation of granulopoietic progenitor cells. , 1999, Blood.

[36]  M. Su,et al.  Interleukin-18 (IFNgamma-inducing factor) induces IL-8 and IL-1beta via TNFalpha production from non-CD14+ human blood mononuclear cells. , 1998, The Journal of clinical investigation.

[37]  B. Cohen,et al.  The human interferon α β receptor: Characterization and molecular cloning , 1994, Cell.

[38]  R. Falk,et al.  Novel effects of neutrophil-derived proteinase 3 and elastase on the vascular endothelium involve in vivo cleavage of NF-kappaB and proapoptotic changes in JNK, ERK, and p38 MAPK signaling pathways. , 2002, Journal of the American Society of Nephrology : JASN.

[39]  P. Patston,et al.  Release and degradation of angiotensin I and angiotensin II from angiotensinogen by neutrophil serine proteinases. , 2002, Archives of biochemistry and biophysics.

[40]  R. Kettritz,et al.  Apoptosis of endothelial cells induced by the neutrophil serine proteases proteinase 3 and elastase. , 1996, The American journal of pathology.

[41]  B. Prum,et al.  A large subset of neutrophils expressing membrane proteinase 3 is a risk factor for vasculitis and rheumatoid arthritis. , 1999, Journal of the American Society of Nephrology : JASN.

[42]  P. Bongrand,et al.  Interleukin-1 induces interleukin-8 secretion from endothelial cells by a juxtacrine mechanism. , 1994, Blood.

[43]  D. Alcorta,et al.  Expression profile of leukocyte genes activated by anti-neutrophil cytoplasmic autoantibodies (ANCA). , 2002, Kidney international.

[44]  G. D. Hunter,et al.  Essential role for proteinase-activated receptor-2 in arthritis. , 2003, The Journal of clinical investigation.

[45]  G. Fantuzzi,et al.  Interleukin-18 binding protein: a novel modulator of the Th1 cytokine response. , 1999, Immunity.

[46]  C. Pham,et al.  Dipeptidyl peptidase I activates neutrophil-derived serine proteases and regulates the development of acute experimental arthritis. , 2002, The Journal of clinical investigation.

[47]  D. Alcorta,et al.  Circumvention of normal constraints on granule protein gene expression in peripheral blood neutrophils and monocytes of patients with antineutrophil cytoplasmic autoantibody-associated glomerulonephritis. , 2004, Journal of the American Society of Nephrology : JASN.

[48]  D. Wallach,et al.  Purification of soluble cytokine receptors from normal human urine by ligand-affinity and immunoaffinity chromatography. , 1990, Journal of chromatography.

[49]  D. Yoon,et al.  Interleukin-32: a cytokine and inducer of TNFalpha. , 2005, Immunity.